131 related articles for article (PubMed ID: 34580909)
1. Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods.
Fisher NC; Loughrey MB; Coleman HG; Gelbard MD; Bankhead P; Dunne PD
Histopathology; 2022 Feb; 80(3):485-500. PubMed ID: 34580909
[TBL] [Abstract][Full Text] [Related]
2. Differential clinical impacts of tumour budding evaluated by the use of immunohistochemical and haematoxylin and eosin staining in stage II colorectal cancer.
Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Shimazaki H; Hase K; Ueno H
Histopathology; 2019 Jun; 74(7):1005-1013. PubMed ID: 30698857
[TBL] [Abstract][Full Text] [Related]
3. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
4. Fully Automated Tumor Bud Assessment in Hematoxylin and Eosin-Stained Whole Slide Images of Colorectal Cancer.
Bokhorst JM; Ciompi F; Öztürk SK; Oguz Erdogan AS; Vieth M; Dawson H; Kirsch R; Simmer F; Sheahan K; Lugli A; Zlobec I; van der Laak J; Nagtegaal ID
Mod Pathol; 2023 Sep; 36(9):100233. PubMed ID: 37257824
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
[TBL] [Abstract][Full Text] [Related]
6. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
[TBL] [Abstract][Full Text] [Related]
7. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Jepsen RK; Klarskov LL; Lippert MF; Novotny GW; Hansen TP; Christensen IJ; Høgdall E; Riis LB
Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
[TBL] [Abstract][Full Text] [Related]
8. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
Eriksen AC; Andersen JB; Lindebjerg J; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
Diagn Pathol; 2018 Mar; 13(1):20. PubMed ID: 29558947
[TBL] [Abstract][Full Text] [Related]
9. Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning.
Bokhorst JM; Blank A; Lugli A; Zlobec I; Dawson H; Vieth M; Rijstenberg LL; Brockmoeller S; Urbanowicz M; Flejou JF; Kirsch R; Ciompi F; van der Laak JAWM; Nagtegaal ID
Mod Pathol; 2020 May; 33(5):825-833. PubMed ID: 31844269
[TBL] [Abstract][Full Text] [Related]
10. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections.
Väyrynen JP; Lau MC; Haruki K; Väyrynen SA; Dias Costa A; Borowsky J; Zhao M; Fujiyoshi K; Arima K; Twombly TS; Kishikawa J; Gu S; Aminmozaffari S; Shi S; Baba Y; Akimoto N; Ugai T; Da Silva A; Song M; Wu K; Chan AT; Nishihara R; Fuchs CS; Meyerhardt JA; Giannakis M; Ogino S; Nowak JA
Clin Cancer Res; 2020 Aug; 26(16):4326-4338. PubMed ID: 32439699
[TBL] [Abstract][Full Text] [Related]
12. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
Mehta A; Goswami M; Sinha R; Dogra A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2447-2453. PubMed ID: 30255698
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis between multilevel sectioning with conventional haematoxylin and eosin staining and immunohistochemistry for detecting nodal micrometastases with stage I and II colorectal cancers.
Wong YP; Shah SA; Shaari N; Mohamad Esa MS; Sagap I; Isa NM
Asian Pac J Cancer Prev; 2014; 15(4):1725-30. PubMed ID: 24641399
[TBL] [Abstract][Full Text] [Related]
14. Arrest of cell proliferation in budding tumor cells ahead of the invading edge of colonic carcinomas. A preliminary report.
Rubio CA
Anticancer Res; 2008; 28(4C):2417-20. PubMed ID: 18751428
[TBL] [Abstract][Full Text] [Related]
15. Automated annotations of epithelial cells and stroma in hematoxylin-eosin-stained whole-slide images using cytokeratin re-staining.
Brázdil T; Gallo M; Nenutil R; Kubanda A; Toufar M; Holub P
J Pathol Clin Res; 2022 Mar; 8(2):129-142. PubMed ID: 34716754
[TBL] [Abstract][Full Text] [Related]
16. Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer.
Bokhorst JM; Nagtegaal ID; Zlobec I; Dawson H; Sheahan K; Simmer F; Kirsch R; Vieth M; Lugli A; van der Laak J; Ciompi F
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046742
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
18. Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters.
Pai RK; Hartman D; Schaeffer DF; Rosty C; Shivji S; Kirsch R; Pai RK
Histopathology; 2021 Sep; 79(3):391-405. PubMed ID: 33590485
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data.
Trinh A; Lädrach C; Dawson HE; Ten Hoorn S; Kuppen PJK; Reimers MS; Koopman M; Punt CJA; Lugli A; Vermeulen L; Zlobec I
Br J Cancer; 2018 Nov; 119(10):1244-1251. PubMed ID: 30385823
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
